II. Mechanism
- Ketamine-like drug of abuse used for its dissociative effects
- Grey market, designer drug
III. Adverse Effects
- Marketed to have less Nausea and Vomiting than Ketamine
- Cerebellar effects (may be longer lasting)
- Nystagmus
- Truncal Ataxia (wide-based drunken gait)
- Difficulty performing Rapid Alternating Movements
- Shields (2012) Clin Toxicol 50(5): 438-40 [PubMed]
IV. Labs: Urine Drug Screen
- Assay for PCP will likely be positive
V. Management: Agitation
VI. References
- Nordt and Swadron in Majoewsky (2012) EM:Rap 12(11): 9
- Wood (2012) Eur J Clin Pharmacol 68(5):853-6 [PubMed]